Content area
Full Text
San Diego-based Anadys Pharmaceuticals Inc., a drug research firm that develops small molecule treatments for viral and bacterial infections, is expected to announce within days that it has completed a financing round led by Care Capital LLC for as much as $30 million, a source close to the company said.
On Monday, June 24, the company said it had appointed Argeris "Jerry" Karabelas, a partner at Care Capital and a former executive with Swiss drugs giant Novartis AG, to its board of directors. Such appointments are often made in conjunction with a major funding event at privately...